Skip Navigation

Evidence-Based Toxicology Collaboration

Scientific Advisory Council

The primary role of the Scientific Advisory Council (SAC) at the EBTC is to provide the expertise needed to develop the new EBT methods, to conduct specific projects and to advise the Board and the EBTC Director on new areas of research and other scientific issues of relevance to the broader toxicology community.

The Governance of the Scientific Advisory Council

The SAC reports to the Director of EBTC and the Board of Trustees. The Board of Trustees elects members of the SAC and nominates the SAC Chair. Dr. Rob de Vries, whose is an expert in development of tools and guidelines to facilitate the conduct of systematic reviews at SyRCLE, Radboud University Nijmegen Medical Centre has been nominated by the Board to be the first Chairman of the SAC.

The EBTC Scientific Advisory Council Members:

  • Elisa Aiassa, DVM, PhD, European Food Safety Authority, Parma, Italy
  • Alan Boobis, Ph.D., Imperial College, London, UK
  • Vince Cogliano, Ph.D., Integrated Risk Information System (IRIS), U.S. Environmental Protection Agency, Washington, DC, USA
  • Roger Curren, Ph.D., Institute for In Vitro Sciences, Gaithersburg, MD, USA
  • Hubert Dirven, Ph.D., Norwegian Institute of Public Health, Oslo, Norway
  • Suzanne Fitzpatrick, PhD, US Food and Drug Administration, College Park, MD, USA
  • Julie E. Goodman, Ph.D., DABT, FACE, ATS, Gradient, Cambridge, MA, USA
  • Barry Hardy, PhD, Managing Director of Douglas Connect GmbH and President of the OpenTox Association, Basel, Switzerland
  • Richard S. Judson, PhD, Bioinformatician, US EPA National Center for Computational Toxicology, Research Triangle Park, NC, USA
  • Ian Kimber, University of Manchester, Manchester, UK
  • Prof. Dr. Annette Kopp-Schneider, German Cancer Research Center, Heidelberg, Germany
  • Francis H. Kruszewski, PhD, DABT, American Cleaning Institue, Washington, DC, USA
  • Manoj M. Lalu, MD, PhD, FRCPC, Ottawa Hospital, Ottawa, Canada
  • Miranda W. Langendam, PhD, Evidence Synthesis, Academic Medical Center at the University of Amsterdam, Dutch Cochrane Centre, Netherlands
  • Mariska M. G. Leeflang, PhD, Clinical Epidemiology, Academic Medical Center at the University of Amsterdam, Cochrane Screening and Diagnostic Test Methods Group, Netherlands
  • Malcolm Macleod, BSc(Hons) MBChB PhD FRCP Ed, University of Edinburgh, Scotland, UK and The Edinburgh CAMARADES Group
  • Simin Meydani, DVM, PhD, USDA Human Research Center on Aging at Tufts University, Boston, USA
  • Johanna Rochester, PhD, The Endocrine Disruption Exchange, Paonia, CO, USA
  • Kristina (Kris) Thayer, Ph.D, Director, Integrated Risk Information System (IRIS) Division, US EPA, Research Triangle Park, NC
  • Carl Westmoreland, PhD, Director of Science and Technology, Unilever, Bedford, UK
  • Paul Whaley, Policy From Science, Lancaster, UK
  • Daniele Wikoff, PhD, ToxStrategies, Austin, Texas, USA
  • Robert Wright, MLS, Johns Hopkins University Welch Medical Library, Baltimore, USA